
Potential cost to patient safety as New Zealand debates access to medicinal cannabis
+Print Archive
Practice
Potential cost to patient safety as New Zealand debates access to medicinal cannabis
Wednesday 28 August 2019, 02:30 AM

The New Zealand Government is introducing a scheme for regulating medicinal cannabis
CLINICAL COMMENT
Michelle Glass and John Ashton from the University of Otago discuss whether untested cannabis-based products should enter the New Zealand healthcare system, as proposed by the Government’s recent consultation document
Cannabis-based products will be allowed to bypass usual processes required for medicines in New Zealand and go directly onto the market without any pr